Asad Bashey MD

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Director of Clinical Research for The Blood and Marrow Transplant Program at Northside Hospital.

5670 Peachtree Dunwoody Rd NeSuite 1000Atlanta, GA 30342
Phone+1 404-255-1930
Fax+1 404-459-8510

Dr. Bashey is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bashey's full profile Already have an account?

Education & Training

University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
Univ Dundee- Fac MedClass of 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1994 - 2028
GA State Medical License 2005 - 2027
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Atlanta Magazine: Top Doctors Castle Connolly, 2013-2014, 2014-2022

Clinical Trials

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
COMPLETED
PHASE2
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)
COMPLETED
PHASE1, PHASE2
Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
COMPLETED
PHASE1, PHASE2

Publications & Presentations

PubMed

Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial.
Asad Bashey, Brent Logan, LaQuisa Hill, Heather Symons, Nosha Farhadfar
Blood Advances. 2026-08-25
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival.
Gurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, Temitope Oloyede, Muhammad Bilal Abid
Transplantation and Cellular Therapy. 2026-06-16
Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial.
Joseph Pidala, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine
Transplantation and Cellular Therapy. 2026-06-01

Journal Articles

The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell Transplantation
Leo Luznik, Karen Ballen, Asad Bashey, Hillard M Lazarus, Bipin N Savani, Rizwan Romee, Ephraim J Fuchs, Nature

Abstracts/Posters

Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Graft Versus Host Disease (GVHD) after HLA-Mismatched Haploidentical Transplantation with Post-Transplant Cyclophosphamide Compared to Matched Unrelated Donor: Inciden...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...
Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Improved Survival in Patients Who Undergo Relapse of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Improved Survival of Patients Diagnosed with Severe (Grade 3-4) Acute GVHD or Severe NIH Grade Chronic GVHD in the Current Era Compared to Historic Controls
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
The Choice of Induction Regimen Affects Post Remission Survival of Acute Myelogenous Leukemia (AML) Patients with Intermediate or Poor Risk Disease
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018